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Purpose: The distribution of atherosderotic arterial disease in diabetes mellitus character- 
istically involves the infragenicular arterial tree including the anterior tibial, posterior 
tibial, and peroneal arteries. The proliferation of vascular smooth muscle cell (VSMC) is 
essential in the development of the atherosclerotic lesion. It  has long been held that 
insulin plays a causative role in the formation of the atherosclerotic lesion in diabetes. We 
studied the role played by insulin in the proliferation of these cells in culture and the 
interaction of insulin with transforming growth factor beta 1 (TGFI~I), a factor known 
for its possible inhibitory effects. 
Methods: We have grown and characterized a line of VSMC harvested from atherosclerotic 
infragenicular arteries of human subjects undergoing below-knee amputation. The cul- 
tures were defined as being of VSMC origin by immunohistochemical staining with 
or-smooth muscle actin. Confluent cultures of passages 4 through 7 were seeded into six 
well plates at a density of 5000 cells/well. After serum deprivation the c lls were exposed 
to insulin (100 ng/ml)  alone or in combination with TGFI~I (6 ng/ml). 
Results: Our findings indicate that a 48-hour incubation with insulin augments the 
proliferation of human infragenicular VSMC, producing a 207% increase in cell number 
when compared with control cells (11,328 - 686, n = 56 vs 3682 -+ 182, n = 87; p < 
0.0001). The addition of TGF~I  in combination with insulin abolished the accelerated 
growth rate seen in test groups treated with insulin alone (3614 + 247, n = 32 vs 
11,328 +-- 686, n = 56; p < 0.0001). 
Conclusion: These results strongly suggest hat insulin is a potent stimulant of human 
infragenicular VSMC proliferation. The mitogenic effect of insulin is inhibited by 
TGFI~I, producing proliferation rates comparable to those observed in control cells 
incubated with serum-free media. (J Vasc Surg 1997;25:432-6.) 
Diabetes mellitus has been shown to be an inde- 
pendent risk factor for the development of athero- 
sclerosis) Although atherosclerosis is a systemic dis- 
ease, this pathologic process has a specific pattern of  
distribution in the diabetic patient population. Char- 
acteristically diabetes-associated atherosclerosis af- 
fects the lower extremities, occurring predominantly 
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in the antcrior and posterior tibial and the peroneal 
arteries (collectively called infragenicular peripheral 
vascular disease) and requiring the performance of 
distal bypasses for limb salvage) The proliferation of 
smooth muscle cells within the intimal layer of the 
arterial wall has becn shown to play an integral part in 
the pathogenesis of atherosclerotic lesions. 3In addi- 
tion to its metabolic effects, insulin is believed to be 
an important factor in promoting the atherosclerotic 
process in diabetic patients. ~,s Furthermore, insulin 
has been shown to induce the proliferation of vas- 
cular smooth muscle cells (VSMCs) in culture. 6-8 
In contrast, transforming growth factor beta 1 
(TGF~ 1) has yielded both stimulatory and inhibitory 
effects on cellular proliferation rates; the type of effect 
is dependent on the cell lineage and its degree of 
differentiation. 9,1° Because of the observed pattern of 
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atherosclerosis in the infragenicular arteries of dia- 
betics and the believed importance of insulin on the 
development of the atherosclerotic lesion, we estab- 
lished a line of  VSMC derived from the atheroscle- 
rotic tibial and peroneal arteries of human subjects 
(HA-VSMC). 11 The study was performed to deter- 
mine the effect of complete sera, insulin, and TGF[31 
on the proliferation of these cells. In addition, 
TGF[3 l 's interaction with insulin on the proliferation 
of HA-VSMC was evaluated. 
MATERIAL  AND METHODS 
Isolation o f  the cell line. Segments of human 
infragenicular rteries demonstrating gross evidence 
of atherosclerosis were harvested uring below-knee 
amputations in diabetic patients. After several wash- 
ings with phosphate-buffered saline solution, the 
adventitial layer was dissected and discarded. The 
tubular arterial segment was then incised longitu- 
dinally, and the calcified plaque was removed. The 
remaining arterial wall, composed primarily of me- 
dia, was minced into pieces approximately I mm 2 
in size. The minced pieces then underwent enzy- 
matic dispersion with the digestive nzymes colla- 
genase and elastase (Worthington Biochemical, 
Freehold, N.J.) at concentrations of  0.1% and 
0.08%, respectively. After a 3- to 5-hour incuba- 
tion in a 37 ° C shaking water bath, the suspension 
was filtered and pelleted. The resultant cellular 
pellet was resuspended in C199 medium contain- 
ing 10% fetal bovine sera (FBS) and 1% antibiotic- 
antimycotic and was plated in 35 cm 2 tissue cul- 
ture flasks. The resultant cultures were identified as 
being of  smooth muscle origin by immunohisto- 
chemical staining techniques with s -smooth  mus- 
cle actin (Sigma Chemical, St. Louis, Mo.). For 
purposes of  our experimentation cultures of  pas- 
sages 4 through 7 were used. 
Serum growth studies. To evaluate the effect of 
varying serum concentrations on the growth of this 
cell line, confluent cultures were detached with 
0.25% trypsin-ethylenediamine t traacetic acid 
(Gibco BRL, Grand Island, N.Y.). The liberated sin- 
gle cell suspension was seeded into six well plates at a 
density of 5000 cells per well. After an initial incuba- 
tion period that allowed for cellular attachment, me- 
dia supplemented with FBS in concentrations rang- 
ing from 0% to 20% were added to each test sample. 
Each experimental condition was evaluated on a daily 
basis by obtaining cell counts with a standard hemo- 
cytometer. Matched control samples were main- 
tained for each test subject hroughout the duration 
of the protocol. 
Insulin dose response studies. The role of var- 
ious insulin concentrations on the proliferation of 
the HA-VSMC was determined through a series of  
dose response xperiments. After an initial 48-hour 
incubation in media containing 10% FBS, the six well 
plates seeded with a single cell suspension were de- 
prived of serum for the remainder of the test period. 
Insulin was delivered at four different concentrations 
ranging from 1 ng/ml  to 1000 ng/ml  to each test 
well. After 72 hours of exposure to the insulin-en- 
riched media, each sample was counted with a stan- 
dard hemocytomcter. 
Prol iferation assays. Confluent cultures of HA- 
VSMC were trypsinized and seeded into six well 
plates at a density of  5000 cells/well. Growth media 
containing 10% FBS were added for a final volume of 
2.5 ml per well. The plates were then incubated in a 
5% CO 2 incubator for 72 hours at 37 ° C. All samples 
were then subjected to a 24-hour period of serum 
starvation. After serum deprivation i sulin (100 ng /  
ml) was added to each test well. In a second series of 
experiments TGFJ31 (6 ng/ml)  was administered 
alone and in conjunction with insulin (100 ng/ml).  
These concentrations were used because of their 
known mitogenic effect in culture systems. Control 
samples were maintained in serum-free media for the 
duration of the experimental period. Both control 
and experimental samples were incubated for an ad- 
ditional 48 hours. Subsequently exposure to the ex- 
ogenous agents was terminated; both control and 
test samples were then counted by hemocytometry. 
Each test condition was replicated a minimum of 
four times. 
Statistical analysis. To analyze the data ob- 
tained a one-way analysis of variance test was used. 
Pairwise multiple comparison procedures (Tukey 
test) were used to further analyze the difference be- 
tween groups. A value ofp less than 0.05 was consid- 
ered to be significant. 
RESULTS 
Immunohistochemical staining of HA-VSMCs 
with c~-smooth muscle actin demonstrated a longitu- 
dinal arrangement of actin filaments typical of 
VSMC. In our serum growth studies we found that a 
serum concentration of 10% is necessary to maintain 
a stable cellular population. This observation is de- 
picted in Fig. 1, which demonstrates a minimal 
change in cell number (5000, n = 15 vs 6473 2 
223, n = 18; p = NS) after a 96-hour incubation in 
media supplemented with 10% FBS. In contrast, 
samples treated with media containing 20% FBS had 
a statistically significant rise in cell density of 62% 
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Fig. 1. Average cell number achieved with 5-day incubation i  various erum concentrations 
ranging from 0% to 20%. Determination of cell density was obtained on daily basis with 
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Fig, 2, Dose response studies in which insulin concentra- 
tions ranging from 1 ng/ml to 1000 ng/ml were used. 
Each value represents average cell number obtained. *p < 
0.0005 when compared with previous concentration. 
from baseline (5000, n = 15 vs 8073 -+ 260, n = 18; 
p < 0.0001) and a 282% increase in cell population 
when compared with serum-deprived cells (8073 -+ 
260, n = 18 vs 2114 - 187, n = 17; p < 0.0001) 
during the same time period. The importance of 
serum for the growth of this cell line is highlighted 
by the 58% loss of cell number seen in samples 
exposed to serum-free media (5000, n = 15 vs 
2114 -+ 187, n = 17, p < 0.0001). 
In the HA-VSMC line insulin affects the cellular 
proliferation rate in a dose-dependent manner. The 
potent effect of insulin on cellular proliferation rates 
in this line of HA-VSMC is shown in Fig. 2. The 
results of our dose response experiments revealed 
that insulin at a concentration of 1 ng/ml  did not 
significantly augment cell density in comparison with 
control cells (4883 -+ 461, n = 7vs 4465 +- 408, n = 
8; p = NS). However, when compared with control 
samplcs, insulin doses of 10 ng/ml,  100 ng/ml,  and 
1000 ng/ml  all produccd significant rises in cell 
number of 71%, 291%, and 386%, respectively. Addi- 
tional analysis of the experimental findings demon- 
strated that an insulin concentration of 100 ng/ml  
resulted in a statistically significant increase in cell 
density when compared with samples treated with an 
insulin dose of 10 ng/ml  (I7,490 + 1238, n = 6 vs 
7639 + 842, n = 9; p < 0.0001). In contrast, no 
significant difference in cell number was observed 
between the groups treated with 100 ng/ml  and 
1000 ng/ml  of insulin (17,490 -+ 1238, n = 6 vs 
21,702 + 2336, n = 9; p = NS), indicating that a 
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plateau in the cell's ability to respond had been 
reached. Forty-eight hours of exposure to insulin at a 
concentration of  100 ng/ml  resulted in a 127% in- 
crease in HA-VSMC cell number when compared 
with the baseline cell number (11,328 --+ 686, n = 
56 vs 5000, n = 15; p < 0.0005). During this same 
time period control samples incubated in serum-free 
media had a 26% decline in cell density (3682 _+ 182, 
n = 87 vs 5000, n = 15; p = NS). A comparison of 
the control and insulin-treated samples at 48 hours 
revealed a net 207% increase in cell density among 
the insulin-treated cells (3682 + 182, n = 87 vs 
11,328 _+ 686, n = 56;p < 0.0001). 
TGF[31 administration i  combination with insu- 
lin abolished the stimulatory effect of insulin 
(3614 -- 247, n = 32vs 11,328 __- 686, n = 56;p< 
0.0001). Samples exposed to the combination of 
insulin and TGF[31 resulted in a cell number not 
significantly different from that of the control group 
(3614 -+ 247, n = 87 vs 3682 _+ 182, n = 32;p = 
NS) (Fig. 3). When compared with baseline this 
result reflected a decline in cell number in the sam- 
ples treated with the combination of  insulin and 
TGF[31 (5000, n = 15 vs 3614 -+ 247, n = 32; p = 
NS). Of note, TGF[31 alone did not influence the 
growth of these cells and resulted in a cell number 
not significantly different from that of the control 
group (3338 -- 236, n = 22 vs 3682 _+ 182, n = 87; 
p = NS) (Fig. 3). 
DISCUSSION 
Diabetes mellitus remains a significant clinical 
problem in the United States with a 6.6% prevalence 
in the adult population. 12 Lower extremity periph- 
eral vascular disease is a serious morbidity associated 
with diabetes mellitus requiring arterial bypass proce- 
dures to achieve limb salvage) Central to the devel- 
opment of atherosclerotic lesions is the VSMC. 
VSMCs from the arterial media migrate to the intima 
after an insult to the endothelium occurs. Within the 
intima, VSMCs undergo proliferation to form the 
core of the atherosclerotic plaque. The mature lesion 
consists of this core in addition to a connective tissue 
matrix and variable amounts of lipids. The luminal 
aspect of the plaque is generally covered by a fibrous 
cap composed of VSMCs and connective tissue? It 
has been postulated that the development of athero- 
sclerosis is influenced by a variety of growth factors 
including insulin and TGF[31. 
Insulin is a serum hormone composed of 51 
amino acid residues. It is synthesized and secreted by 
the pancreatic 13-cells. After its release, insulin binds 
to a specific cell surface receptor weighing 152 to 
154 kd. The hormone receptor complex activates 
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Fig. 3. Effect of insulin and TGF[31 alone and in combi- 
nation on proliferation of HA-VSMC. *p < 0.0001 when 
compared with all other groups by analysis of variance. 
adenylate cyclase, lowering intracellular cyclic aden- 
osine monophasphate levels and initiating its second 
messenger signaling system. 12 In addition to its ef- 
fects on glucose metabolism, insulin is thought to 
induce cellular proliferation and has been implicated 
in the formation of atherosclerotic lesions. In pa- 
tients with type II diabetes mellitus levels of endog- 
enous insulin may be elevated in response to high 
serum glucose concentrations. In this group of  pa- 
tients insulin receptor esistance and not hypoinsu- 
linemia is the primary defect in glucose metabolism 
leading to hyperglycemia. In addition, hyperglyce- 
mic patients are sometimes given exogenous insulin 
one or two times a day as part of their treatment 
regimen. Therefore, most diabetics are exposed to 
high levels of serum insulin.<S 
TGF[31 is a 112-amino acid monomer initially 
purified from platelets. This member of  a five-mole- 
cule family is capable of binding to any one of four 
receptor types. ~3 Although the exact mechanism re- 
mains unclear, once bound to its receptor's extracel- 
lular domain, TGF[31 has been found to have an 
inhibitory effect on cell proliferation. However, the 
effect of TGF[31 can also be stimulatory in nature, 
promoting cells to proliferate. The nature of 
TGF[31's action on a particular cell depends on fac- 
tors such as cell type, growth conditions, and other 
growth factors present. ~4 The effects of insulin and 
TGF[31 on cellular proliferation have been attributed 
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to their action at the level o f  the cell cycle. According 
to the current hypothesis cells are rendered compe- 
tent by circulating factors that induce the cell to 
progress through the quiescent GO phase into the G1 
phase of  the cell cycle. However, to avoid arrest in 
the G1 phase a progression factor must be intro- 
duced, allowing the cell to traverse the G1 phase into 
the S phase with subsequent DNA synthesis, ls,16 
Through the interaction of  circulating factors such as 
insulin and TGF[~I cellular proliferation is regulated 
at the level o f  the cell cycle. 
Because the proliferation o f  VSMC plays an inte- 
gral role in the formation of  the atherosclerotic le- 
sion, we have studied the effect o f  insulin and TGF~I  
on the proliferative capacity of  VSMC derived from 
infragenicular vessels o f  patients undergoing below- 
lmee amputation because of  ischemia. Our  results 
support the hypothesis that insulin serves as an im- 
portant regulator o f  VSMC proliferation. After the 
administration of  insulin a 127% increase in cell den- 
sity was achieved in 48 hours. During the same time 
period cells incubated in serum-free media had a 26% 
decline in number. Our  dose response experiments 
revealed that the concentration of  insulin found in 
the local cellular environment influences the prolifer- 
ative reaction. At a concentration of  1 ng /ml  insulin 
exerted only a minimal effect, whereas at a dose of  
100 ng /ml  insulin administration produced a 291% 
rise in cell number. Further testing demonstrated no 
significant increases in proliferation with the delivery 
of  higher insulin doses, suggesting either saturation 
of  the cell surface receptor or an inability to further 
upregulate cellular metabolism. 
The effect observed with the administration of  
insulin alone was abolished with the addition of  
TGF[31. TGF[31 is known to exert its inhibitory 
effect in the latter part o f  G 1 phase of  the cell cycle, 
when insulin exerts its stimulatory effect} 6 This in- 
teraction among various growth factors is important 
in the proliferation of  smooth muscle cell, which 
plays a significant role in the formation of  the athero- 
sclerotic lesion. Because diabetic peripheral vascular 
disease is characteristically distributed in the infra- 
genicular vasculature in humans, and TGF[31 effec= 
tively inhibits insulin's proliferative ffect on VSMC 
derived from that location, manipulating these 
growth factors or their receptors may prove impor- 
tant in slowing or preventing the progress o f  the 
atherosclerotic process. 
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